✦ LIBER ✦

Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor

✍ Scribed by Philippe Dostert; Margherita S. Benedetti; Italo Poggesi

Book ID: 118599640
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 885 KB
Volume: 7
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(97)00417-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism and Pharmacokinetics of Selec

Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

✍ C. Lindsay DeVane 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 114 KB

Clinical Pharmacokinetics of Reboxetine,

Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression

✍ Dr Joseph C. Fleishaker 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 216 KB

Rapid remission of atypical depressive s

Rapid remission of atypical depressive symptoms with the selective noradrenalin reuptake inhibitor reboxetine in SAD patients

✍ E. Hilger; M. Willeit; N. Praschak-Rieder; A. Neumeister; J. Stastny; N. Thierry 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Reboxetine, a selective noradrenaline re

Reboxetine, a selective noradrenaline reuptake inhibitor, is non-sedative and does not impair psychomotor performance in healthy subjects

✍ Werner M. Herrmann; Hermann Fuder 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

A double-blind, randomized, four-way crossover study was performed to assess the CNS eects of reboxetine, a unique selective noradrenaline reuptake inhibitor (NRI). Eighteen volunteers received reboxetine (1 or 3 mg), imipramine (75 mg) or placebo at weekly intervals. Pharmaco-electroencephalography

Discriminative stimulus properties of th

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

✍ Anne Dekeyne; Alain Gobert; Loretta Iob; Laetitia Cistarelli; Christophe Melon; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 62 KB

Milnacipran: The Clinical Properties of

Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

✍ Y. Lecrubier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological pro®le of milnacipran suggested that the drug would be therapeutically eective and well tolerat